title: Lamivudine and rapid regeneration of the atrophic liver in decompensated cirrhosis due to hepatitis B.
authors.forename: Takafumi
authors.initials: T
authors.lastname: Saito
authors.forename: Haruhide
authors.initials: H
authors.lastname: Shinzawa
authors.forename: Hisayoshi
authors.initials: H
authors.lastname: Watanabe
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Sugahara
authors.forename: Kazuo
authors.initials: K
authors.lastname: Okumoto
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Togashi
authors.forename: Sumio
authors.initials: S
authors.lastname: Kawata
mesh_terms: D001284:Atrophy / Q000473:pathology; D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000000981:diagnostic imaging; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage*; D008103:Liver Cirrhosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology*; D008111:Liver Function Tests; D008115:Liver Regeneration / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D012720:Severity of Illness Index; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine